Updated results from a phase III trial of sunitinib versus placebo in patients with progressive, unresectable, well-differentiated pancreatic neuroendocrine tumor (NET).
Aaron Vinik
Honoraria - Pfizer; Pfizer
Research Funding - Pfizer; Pfizer
Other Remuneration - Pfizer; Pfizer
Eric Van Cutsem
Research Funding - Pfizer
Patricia Niccoli
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Pfizer
Jean-Luc Raoul
No relevant relationships to disclose
Yung-Jue Bang
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Research Funding - Pfizer
Ivan Borbath
No relevant relationships to disclose
Juan W. Valle
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Peter Metrakos
No relevant relationships to disclose
Denis Smith
No relevant relationships to disclose
Jen-Shi Chen
Honoraria - Novartis; Pfizer
Dieter Hoersch
Consultant or Advisory Role - Ipsen; Novartis; Pfizer
Honoraria - Novartis; Pfizer
Research Funding - Covidien; Eckert and Ziegler ; Ipsen; MDS Nordion; Novartis
Daniel E. Castellano
No relevant relationships to disclose
Hagen F. Kennecke
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Expert Testimony - Pfizer (U)
Joel Picus
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer
Guy Van Hazel
No relevant relationships to disclose
Shem Patyna
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Dongrui (Ray) Lu
Employment or Leadership Position - Pfizer (B)
Stock Ownership - Pfizer (B)
Richard C. Chao
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Eric Raymond
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Research Funding - Pfizer